Business · 07/02/2018Updated: 10/17/2026 · 1 min read
FDA Determines Regulatory Review Period for SEDASYS SYSTEM Patent Extension
Summary
The US Food and Drug Administration (FDA) has officially announced its decision regarding the regulatory review period for SEDASYS SYSTEM, a medical device patent extension application submitted to the US Patent and Trademark Office (USPTO).
Original source language: Federal Register — Food and Drug AdministrationOpen original release →